For some time the medical treatment of glaucoma has consisted of topical β-blockers,
adrenergic agents, miotics and oral carbonic anhydrase inhibitors (CAIs). However, the …

Background Primary open angle glaucoma (POAG) is a progressive optic neuropathy with
an elevated intraocular pressure (IOP), where the optic nerve head becomes pathologically …

Topical β-blockers reduce the intraocular pressure (IOP) by blockade of sympathetic nerve
endings in the ciliary epithelium causing a fall in aqueous humour production. Two types of …

Elevated intraocular pressure (IOP) has been recognized as the major risk factor for the
development of glaucoma and a wide range of options are now available to reduce it …

Since the late 1970s, topical β‐adrenergic blockers have been the drugs of choice in
treating ocular hypertension and associated glaucoma. The currently available drugs are …

Es ist das Verdienst von Professor Günter K. Krieglstein, das weltweit verwendete
Standardwerk über Glaukome von M. Bruce Shields ins Deutsche übersetzt und im Hinblick …

• We performed a double-masked, cross-over, dose-response study of apraclonidine
hydrochloride (formerly known as ALO 2145) in 20 patients with elevated intraocular …

Although twice-daily instillation of topical beta-blockers is the standard regimen for treatment
of increased intraocular pressure, once-daily therapy might improve patient compliance and …

OBJECTIVE: To compare the similarities and differences among the ocular beta-blockers.
Important considerations when comparing these agents are the differences in systemic …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …